Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope?

Author:

Hurt Aeron12,Komadina Naomi2,Deng Yi-Mo2,Kaye Matthew2,Sullivan Sheena32,Subbarao Kanta12,Barr Ian12

Affiliation:

1. Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia

2. WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia

3. School of Global and Population Health, The University of Melbourne, Victoria, Australia

Abstract

For over a decade virtually all A(H3N2) influenza viruses have been resistant to the adamantane class of antivirals. However, during the 2017 influenza season in Australia, 15/461 (3.3%) adamantane-sensitive A(H3N2) viruses encoding serine at residue 31 of the M2 protein were detected, more than the total number identified globally during the last 6 years. A return to wide circulation of adamantane-sensitive A(H3N2) viruses would revive the option of using these drugs for treatment and prophylaxis.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference18 articles.

1. Amantadine and rimantadine for preventing and treating influenza A in adults.;Jefferson;Cochrane Database Syst Rev,2004

2. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine.;Hayden;Curr Top Microbiol Immunol,1992

3. Low incidence of rimantadine resistance in field isolates of influenza A viruses.;Ziegler;J Infect Dis,1999

4. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.;Bright;Lancet,2005

5. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.;Bright;JAMA,2006

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3